本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ovid Therapeutics Inc.

1.45
-0.0400-2.68%
盘后1.450.00000.00%19:22 EDT
成交量:113.75万
成交额:166.71万
市值:1.03亿
市盈率:-2.71
高:1.53
开:1.53
低:1.44
收:1.49
52周最高:2.01
52周最低:0.2425
股本:7,110.95万
流通股本:5,952.45万
量比:0.74
换手率:1.91%
股息:- -
股息率:- -
每股收益(TTM):-0.5359
每股收益(LYR):-0.3663
净资产收益率:-52.77%
总资产收益率:-26.71%
市净率:1.85
市盈率(LYR):-3.96

数据加载中...

2021/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/15

重要事件披露

8-K - Current report
2021/03/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/03

重要事件披露

8-K - Current report
2021/03/03

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/21

重要事件披露

8-K - Current report
2020/12/01

重要事件披露

8-K - Current report
2020/11/18

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/10/22

重要事件披露

8-K - Current report
2020/09/30

重要事件披露

8-K - Current report